Edwards Lifesciences (EW) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
iRadimed (IRMD) has outperformed Edwards Lifesciences (EW) over the past year, gaining 14.9% versus a gain of 11.8%. Over five years, IRMD leads with a +133.1% price change compared with -23.5% for EW. Edwards Lifesciences is the larger company by market cap ($47.74 billion vs $1.09 billion), about 44.0 times the size.
On valuation, Edwards Lifesciences trades at a lower forward P/E (24.5x vs 34.6x for iRadimed). iRadimed pays a dividend yielding 0.91%, while Edwards Lifesciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | IRMD |
|---|---|---|
| Share price | $82.82 | $84.90 |
| Market cap | $47.74B | $1.09B |
| 1-day change | -3.45% | -0.67% |
| YTD return | +0.62% | -12.14% |
| 1-year return | +11.81% | +14.93% |
| 5-year return | -23.52% | +133.08% |
| P/E ratio (TTM) | 49.30 | 47.43 |
| Forward P/E | 24.48 | 34.61 |
| EPS (TTM) | $1.68 | $1.79 |
| Dividend yield | 0.00% | 0.91% |
| Annual dividend | $0.00 | $0.77 |
| Revenue (latest FY) | $6.07B | — |
| Revenue growth (YoY) | +11.55% | — |
| Net income (latest FY) | $1.07B | — |
| Gross margin | 78.01% | — |
| Operating margin | 20.84% | — |
| Net margin | 17.69% | — |
| 52-week high | $96.29 | $107.90 |
| 52-week low | $72.30 | $71.34 |
| Distance from 52-week high | -13.99% | -21.32% |
| Analyst consensus | buy | none |
| Avg. price target upside | +23.11% | +38.99% |
| Average volume | 3.82M | 126.03K |
| Shares outstanding | 576.40M | 12.79M |
| Employees | 16,000 | 166 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 44.0 times larger than iRadimed by market value ($47.74B vs $1.09B).
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
EW vs IRMD FAQ
Which is bigger, Edwards Lifesciences or iRadimed?
Edwards Lifesciences (EW) is larger, with a market capitalization of $47.74B compared with $1.09B for iRadimed (IRMD).
Which stock has performed better over the past year, EW or IRMD?
IRMD returned +14.93% over the past 12 months, compared with +11.81% for EW (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or IRMD?
IRMD has the lower trailing P/E at 47.4, versus 49.3 for EW. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or iRadimed?
iRadimed pays a dividend yielding 0.91%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and iRadimed in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Edwards Lifesciences and Medical/Dental Instruments for iRadimed.